MHRA assesses cost to industry of complying with new law on falsified medicines
This article was originally published in Scrip
Executive Summary
The UK regulatory body, the MHRA, says it plans to begin a public consultation this spring on implementing the EU's falsified medicines directive, many of whose provisions are due to come into force on 2 January next year.